Connect with us

Technology

ELBIT SYSTEMS REPORTS THIRD QUARTER 2024 RESULTS

Published

on

Order backlog at $22.1 billion; Revenues of $1.7 billion;
Non-GAAP net income of $99 million; GAAP net income of $79 million;
Non-GAAP net EPS of $2.21; GAAP net EPS of $1.77 

HAIFA, Israel, Nov. 19, 2024 /PRNewswire/ — Elbit Systems Ltd. (“Elbit Systems” or the “Company”) (NASDAQ: ESLT) (TASE: ESLT), the international high technology defense company, reported today its consolidated results for the third quarter ended September 30, 2024.

In this release, the Company is providing US-GAAP results as well as non-GAAP financial data, which are intended to provide investors a more comprehensive view of the Company’s business results and trends. For a description of the Company’s non-GAAP definitions see page 4 below, “Non-GAAP financial data”. Unless otherwise stated, all financial data presented is US-GAAP financial data.

Management Comment:

Bezhalel (Butzi) Machlis, President and CEO of Elbit Systems, commented: 

“Elbit Systems reports a strong quarter, with substantial growth across key performance measures exceeding our internal goals, while meeting our customers’ needs in Israel and worldwide. The Company’s order backlog, which hit a record high of over $22 billion, provides stability and resilience for the Company for years to come, as our investments in R&D create strong foundations for long-term growth and development. Our highly regarded solutions and products are experiencing high demand. This consistent growth reflects the quality and excellence driven by our dedicated and outstanding employees in Israel and in our subsidiaries around the world.”

Third quarter 2024 results:

Revenues in the third quarter of 2024 were $1,717.5 million, as compared to $1,501.6 million in the third quarter of 2023.

Aerospace revenues increased by 7% in the third quarter of 2024, as compared to the third quarter of 2023 mainly due to increased UAS sales in Israel. C4I and Cyber revenues increased by 13% in the third quarter of 2024 mainly due to radio systems and command and control systems sales. ISTAR and EW revenues increased by 13% mainly due to Electronic Warfare and Electro-Optic systems sales. Land revenues increased by 24% due to the increase in ammunition and munition sales in Israel. Elbit Systems of America revenues increased by 17% due to the increase in night-vision systems and medical instrumentation sales.

For distribution of revenues by segments and geographic regions see the tables on page 12.

Non-GAAP(*) gross profit amounted to $419.4 million (24.4% of revenues) in the third quarter of 2024, as compared to $374.2 million (24.9% of revenues) in the third quarter of 2023. GAAP gross profit in the third quarter of 2024 was $412.8 million (24.0% of revenues), as compared to $367.2 million (24.5% of revenues) in the third quarter of 2023.

Research and development expenses, net were $119.9 million (7.0% of revenues) in the third quarter of 2024, as compared to $103.3 million (6.9% of revenues) in the third quarter of 2023.

Marketing and selling expenses, net were $91.3 million (5.3% of revenues) in the third quarter of 2024, as compared to $86.0 million (5.7% of revenues) in the third quarter of 2023.

General and administrative expenses, net were $75.7 million (4.4% of revenues) in the third quarter of 2024, as compared to $71.8 million (4.8% of revenues) in the third quarter of 2023.

Non-GAAP(*) operating income was $140.7 million (8.2% of revenues) in the third quarter of 2024, as compared to $120.0 million (8.0% of revenues) in the third quarter of 2023. GAAP operating income in the third quarter of 2024 was $125.8 million (7.3% of revenues), as compared to $106.1 million (7.1% of revenues) in the third quarter of 2023.

Financial expenses, net were $45.0 million in the third quarter of 2024, as compared to $35.7 million in the third quarter of 2023.

Taxes on income were $12.8 million in the third quarter of 2024, as compared to $10.0 million in the third quarter of 2023.

Non-GAAP(*) net income attributable to the Company’s shareholders in the third quarter of 2024 was $98.8 million (5.8% of revenues), as compared to $76.5 million (5.1% of revenues) in the third quarter of 2023. GAAP net income attributable to the Company’s shareholders in the third quarter of 2024 was $79.1 million (4.6% of revenues), as compared to $60.7 million (4.0% of revenues) in the third quarter of 2023.

Non-GAAP(*) diluted net earnings per share attributable to the Company’s shareholders were $2.21 for the third quarter of 2024, as compared to $1.71 for the third quarter of 2023. GAAP diluted earnings per share attributable to the Company’s shareholders in the third quarter of 2024 were $1.77, as compared to $1.36 in the third quarter of 2023.

The Company’s order backlog as of September 30, 2024 totaled $22.1 billion. Approximately 66% of the current backlog is attributable to orders from outside Israel. Approximately 37% of the backlog is scheduled to be performed during the remainder of 2024 and 2025. 

Cash flow provided by operating activities in the nine months ended September 30, 2024 was $82.5 million, as compared to cash flow used in operating activities of $200.0 million in the nine months ended September 30, 2023. The cash flow in the nine months ended September 30, 2024 was affected mainly by the increase in contract liabilities, which was offset by the increase in inventories and trade receivables.

__________                    

* see page 4

Impact of the “Swords of Iron” War on the Company:

On October 7, 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of brutal attacks on civilian and military targets. Hamas also launched extensive rocket attacks on the Israeli population and industrial centers located along Israel’s border with the Gaza Strip and on many other parts of the country. Israel has also been attacked by other terrorist organizations on different fronts, including from Lebanon, which have prompted military responses from Israel on these fronts. Following the attacks, the State of Israel declared a state of war, which is ongoing.

Since the commencement of hostilities, Elbit Systems has experienced a material increased demand for its products and solutions from the Israel Ministry of Defense (IMOD) compared to the demand levels prior to the war. The Company has also increased its support to the IMOD, mainly through deliveries of its systems and the dedicated efforts of our employees. At the same time, the Company continues its activities in the international markets with the support of its local subsidiaries. Subject to further developments, which are difficult to predict, the IMOD’s increased demand for the Company’s products and solutions may continue and could generate material additional orders for the Company.

While the vast majority of the facilities in Israel continue to operate uninterrupted, some operations have experienced disruptions due to supply chain and operational constraints, including among others due to limitations on exports to Israel, increase of transportation costs and delays, material and component shortages, attacks by anti-Israeli organizations, the relocation of certain production lines, evacuation of employees and employee recruitment for reserve duty. The number of employees recruited was approximately 8% as of September 30, 2024, and could fluctuate depending on future developments.

Elbit Systems has taken a number of steps to protect the safety and the security of its employees in Israel and abroad, to support its increased production, to mitigate existing and potential supply chain disruptions and to maintain business continuity, including the relocation of production lines from facilities in evacuated areas to alternative facilities; recruitment of additional employees; increased monitoring of global supply chains to identify delays, shortages and bottlenecks; rescheduling of deliveries to certain customers as necessary; and an increase of inventories.

The extent of the effects of the war on the Company’s performance will depend on future developments of the war that are difficult to predict at this time, including its duration and scope. We continue to monitor the situation closely.

* Non-GAAP financial data:

The following non-GAAP financial data, including Adjusted gross profit, Adjusted operating income, Adjusted net income, and Adjusted diluted earnings per share, is presented to enable investors to have additional information on our business performance as well as a further basis for periodical comparisons and trends relating to our financial results. We believe such data provides useful information to investors and analysts by facilitating more meaningful comparisons of our financial results over time. The non-GAAP adjustments exclude amortization expenses of intangible assets related to acquisitions that occurred mainly in prior periods, capital gains related primarily to the sale of investments, restructuring activities, uncompensated costs related to “Swords of Iron” war, non-cash stock based compensation expenses, revaluations of investments in affiliated companies, non-operating foreign exchange gains or losses, one-time tax expenses, and the effect of tax on each of these items. We present these non-GAAP financial measures because management believes they supplement and/or enhance management’s, analysts’ and investors’ overall understanding of the Company’s underlying financial performance and trends and facilitate comparisons among current, past, and future periods.

Specifically, management uses Adjusted gross profit, Adjusted operating income, and Adjusted net income attributable to the Company’s shareholders to measure the ongoing gross profit, operating profit and net income performance of the Company because the measure adjusts for more significant non-recurring items, amortization expenses of intangible assets relating to prior acquisitions, and non-cash expense which can fluctuate year to year.

We believe Adjusted gross profit, Adjusted operating income, and Adjusted net income attributable to the Company’s shareholders are useful to existing shareholders, potential shareholders and other users of our financial information because they provide measures of the Company’s ongoing performance that enable these users to perform trend analysis using comparable data.

Management uses Adjusted diluted earnings per share to evaluate further adjusted net income attributable to the Company’s shareholders while considering changes in the number of diluted shares over comparable periods.

We believe adjusted diluted earnings per share is useful to existing shareholders, potential shareholders and other users of our financial information because it also enables these users to evaluate adjusted net income attributable to Company’s shareholders on a per-share basis.

The non-GAAP measures used by the Company are not based on any comprehensive set of accounting rules or principles. We believe that non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our results of operations, as determined in accordance with GAAP, and that these measures should only be used to evaluate our results of operations in conjunction with the corresponding GAAP measures.

Investors are cautioned that, unlike financial measures prepared in accordance with GAAP, non-GAAP measures may not be comparable with the calculation of similar measures for other companies. They should consider non-GAAP financial measures in addition to, and not as replacements for or superior to, measures of financial performance prepared in accordance with GAAP.

Reconciliation of GAAP to Non-GAAP Supplemental Financial Data:

(US Dollars in millions, except for per share amounts)

Nine
months
ended
September
30, 2024

Nine
months
ended
September
30, 2023

Three
months
ended
September
30, 2024

Three
months
ended
September
30, 2023

Year
ended
December
31, 2023

GAAP gross profit

$  1,176.6

$  1,100.8

$     412.8

$     367.2

$  1,483.0

Adjustments:

Amortization of purchased intangible assets(*)

14.8

20.2

4.2

6.6

27.3

Restructuring of a subsidiary’s activities

17.5

Stock based compensation

1.5

1.5

0.7

0.4

1.8

Uncompensated labor costs related to “Swords of Iron” war

6.0

1.7

4.3

Non-GAAP gross profit

$  1,198.9

$  1,122.5

$     419.4

$     374.2

$  1,533.9

Percent of revenues

24.5 %

25.8 %

24.4 %

24.9 %

25.7 %

GAAP operating income

$     347.7

$     301.5

$     125.8

$     106.1

$     369.1

Adjustments:

Amortization of purchased intangible assets(*)

26.5

32.7

8.1

10.9

43.9

Restructuring of a subsidiary’s activities

17.5

Stock based compensation

10.1

9.7

4.4

3.0

12.1

Uncompensated labor costs related to “Swords of Iron” war

8.6

2.4

6.1

Non-GAAP operating income

$     392.9

$     343.9

$     140.7

$     120.0

$     448.7

Percent of revenues

8.0 %

7.9 %

8.2 %

8.0 %

7.5 %

GAAP net income attributable to Elbit Systems’ shareholders

$     231.1

$     185.1

$        79.1

$        60.7

$     215.1

Adjustments:

Amortization of purchased intangible assets(*)

26.5

32.7

8.1

10.9

43.9

Restructuring of a subsidiary’s activities

17.5

Stock based compensation

10.1

9.7

4.4

3.0

12.1

Uncompensated labor costs related to “Swords of Iron” war

8.6

2.4

6.1

Capital gain

(2.0)

(2.0)

Revaluation of investment measured under fair value option

7.4

3.0

Non-operating foreign exchange (gains) losses

(4.2)

5.7

8.1

3.3

12.0

Tax effect and other tax items, net

(5.3)

(4.2)

(1.3)

(1.4)

(10.9)

Non-GAAP net income attributable to Elbit Systems’ shareholders   

$     272.2

$     229.0

$        98.8

$        76.5

$     298.8

Percent of revenues

5.6 %

5.3 %

5.8 %

5.1 %

5.0 %

GAAP diluted net EPS

$        5.18

$        4.15

$        1.77

$        1.36

$        4.82

Adjustments, net

0.92

0.99

0.44

0.35

1.88

Non-GAAP diluted net EPS

$        6.10

$        5.14

$        2.21

$        1.71

$        6.70

(*) While amortization of acquired intangible assets is excluded from the measures, the revenue of the acquired companies is reflected in the measures
and the acquired assets contribute to revenue generation.

 

Recent Events:

On September 20, 2024, the Company announced that at its Annual General Meeting of Shareholders held on September 19, 2024 at the Company’s offices in Haifa, each of the proposals described in the Proxy Statement to the shareholders dated August 15, 2024, was approved by the required majority.

On October 28, 2024, the Company announced that it was awarded an approximately $200 million contract by the Israeli Ministry of Defense to supply high-power laser systems for the “Iron Beam” air defense system.

On November 5, 2024, the Company announced that it was awarded a follow-on contract of approximately $127 million to supply Iron Fist Active Protection Systems to General Dynamics Ordnance and Tactical Systems for upgrades to the U.S. Army’s Bradley M2A4E1 Infantry Fighting Vehicles. The contract will be performed over a period of 34 months.

On November 18, 2024, the Company announced that it was awarded contracts worth a total amount of approximately $335 million, to supply defense systems to a European country. The contracts include the supply of PULS™ (Precise and Universal Launching Systems) rocket launchers and rockets, as well as Hermes™ 900 Unmanned Aircraft Systems equipped with advanced payloads. The contracts will be performed over a period of three years and six months.

Dividend:

The Board of Directors declared a dividend of $0.50 per share. The dividend’s record date is December 23, 2024. The dividend will be paid on January 6, 2025, after deduction of withholding tax, at the rate of 16.8%. 

Conference Call:

The Company will be hosting a conference call today, Wednesday, November 19, 2024, at 10:00 a.m. Eastern Time. On the call, management will review and discuss the results and will be available to answer questions.

To participate, please call one of the teleconferencing numbers that follow. If you are unable to connect using the toll-free numbers, please try the international dial-in number.

US Dial-in Number: 1-866-744-5399
Canada Dial-in Number: 1-866-485-2399
Israel Dial-in Number: 03-918-0644
International Dial-in Number: 972-3-918-0644

at 10:00am Eastern Time; 7:00am Pacific Time; 5:00pm Israel Time

The conference call will also be broadcast live on Elbit Systems’ website at https://www.elbitsystems.com. An online replay will be available from 24 hours after the call ends.

Alternatively, for two days following the call, investors will be able to dial a replay number to listen to the call. The dial-in numbers are: 1-888-782-4291 (US and Canada) or +972-3-925-5900 (Israel and International).

About Elbit Systems

Elbit Systems is a leading global defense technology company, delivering advanced solutions for a secure and safer world. Elbit Systems develops, manufactures, integrates and sustains a range of next-generation solutions across multiple domains.

Driven by its agile, collaborative culture, and leveraging Israel’s technology ecosystem, Elbit Systems enables customers to address rapidly evolving battlefield challenges and overcome threats.

Elbit Systems employs over 20,000 people in dozens of countries across five continents. The Company reported as of September 30, 2024 approximately $1.7 billion in revenues and an order backlog of approximately $22.1 billion.

For additional information, visit: https://elbitsystems.com/, follow us on Twitter or visit our official Facebook, Youtube and LinkedIn channels.

Attachments:

Consolidated balance sheets
Consolidated statements of income
Consolidated statements of cash flows
Consolidated revenue distribution by geographical regions and by segments

Company Contact:

Dr. Yaacov (Kobi) Kagan, EVP & Chief Financial Officer
Tel:  +972-77-2946663
kobi.kagan@elbitsystems.com 

Daniella Finn, VP, Investor Relations
Tel: +972-77-2948984
daniella.finn@elbitsystems.com 

Dalia Bodinger, VP, Communications & Brand
Tel: +972-77-2947602 
dalia.bodinger@elbitsystems.com      

 

This press release may contain forward–looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended and the Israeli Securities Law, 1968) regarding Elbit Systems Ltd. and/or its subsidiaries (collectively the Company), to the extent such statements do not relate to historical or current facts. Forward-looking statements are based on management’s current expectations, estimates, projections and assumptions about future events. Forward–looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions about the Company, which are difficult to predict, including projections of the Company’s future financial results, its anticipated growth strategies and anticipated trends in its business. Therefore, actual future results, performance and trends may differ materially from these forward–looking statements due to a variety of factors, including, without limitation: scope and length of customer contracts; governmental regulations and approvals; changes in governmental budgeting priorities; general market, political and economic conditions in the countries in which the Company operates or sells, including Israel and the United States among others; including the duration and scope of the current war in Israel, and the potential impact on our operations; changes in global health and macro-economic conditions; differences in anticipated and actual program performance, including the ability to perform under long-term fixed-price contracts; changes in the competitive environment; and the outcome of legal and/or regulatory proceedings. The factors listed above are not all-inclusive, and further information is contained in Elbit Systems Ltd.’s latest annual report on Form 20-F, which is on file with the U.S. Securities and Exchange Commission. All forward–looking statements speak only as of the date of this release.

Although the Company believes the expectations reflected in the forward-looking statements contained herein are reasonable, it cannot guarantee future results, level of activity, performance or achievements. Moreover, neither the Company nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. The Company does not undertake to update its forward-looking statements.

Elbit Systems Ltd., its logo, brand, product, service and process names appearing in this Press Release are the trademarks or service marks of Elbit Systems Ltd. or its affiliated companies.  All other brand, product, service and process names appearing are the trademarks of their respective holders.  Reference to or use of a product, service or process other than those of Elbit Systems Ltd. does not imply recommendation, approval, affiliation or sponsorship of that product, service or process by Elbit Systems Ltd. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right under any patent, copyright, trademark or other intellectual property right of Elbit Systems Ltd. or any third party, except as expressly granted herein.

(FINANCIAL TABLES TO FOLLOW)

 

ELBIT SYSTEMS LTD.

CONSOLIDATED BALANCE SHEETS

(In thousands of US Dollars)

As of

September 30, 2024

As of

December 31, 2023

Assets

Cash and cash equivalents

$                    119,199

$                    197,429

Short-term bank deposits

4,169

10,518

Trade and unbilled receivables and contract assets, net

3,055,619

2,716,762

Other receivables and prepaid expenses

363,002

285,352

Inventories, net

2,822,733

2,298,019

Total current assets

6,364,722

5,508,080

Investments in affiliated companies and other companies

133,784

145,350

Long-term trade and unbilled receivables and contract assets

458,898

364,719

Long-term bank deposits and other receivables

41,435

87,648

Deferred income taxes, net

23,765

23,423

Severance pay fund

204,724

206,943

Total

862,606

828,083

Operating lease right of use assets

527,943

425,884

Property, plant and equipment, net

1,232,948

1,087,950

Goodwill and other intangible assets, net

1,858,870

1,889,585

Total assets

$              10,847,089

$                 9,739,582

Liabilities and Equity

Short-term bank credit and loans

$                    689,292

$                    576,594

Current maturities of long-term loans and Series B, C and D Notes

74,547

75,286

Operating lease liabilities

78,586

67,390

Trade payables

1,310,636

1,254,126

Other payables and accrued expenses

1,264,973

1,194,347

Contract liabilities

2,129,874

1,656,103

Total current liabilities

5,547,908

4,823,846

Long-term loans, net of current maturities

29,574

41,227

Series B, C and D Notes, net of current maturities

274,902

342,847

Employee benefit liabilities

499,656

510,416

Deferred income taxes and tax liabilities, net

62,464

55,240

Contract liabilities

618,546

354,319

Operating lease liabilities

451,930

363,100

Other long-term liabilities

288,863

298,296

Total long-term liabilities

2,225,935

1,965,445

Elbit Systems Ltd.’s equity

3,069,810

2,947,503

Non-controlling interests

3,436

2,788

Total equity

3,073,246

2,950,291

Total liabilities and equity

$              10,847,089

$                 9,739,582

 

 

ELBIT SYSTEMS LTD.

CONSOLIDATED STATEMENTS OF INCOME

(In thousands of US Dollars, except for share and per share amounts)

Nine months
ended
September 30,
2024

Nine months
ended
September 30,
2023

Three months
ended
September 30,
2024

Three months
ended
September 30,
2023

Year ended
December 31,
2023

Revenues

$     4,897,655

$     4,348,950

$     1,717,547

$     1,501,567

$     5,974,744

Cost of revenues

3,721,036

3,248,104

1,304,763

1,134,393

4,491,790

Gross profit

1,176,619

1,100,846

412,784

367,174

1,482,954

Operating expenses:

Research and development, net

335,210

307,065

119,890

103,315

424,420

Marketing and selling, net

268,144

267,845

91,349

85,967

359,141

General and administrative, net

225,608

224,406

75,736

71,842

330,285

Total operating expenses

828,962

799,316

286,975

261,124

1,113,846

Operating income

347,657

301,530

125,809

106,050

369,108

Financial expenses, net

(105,219)

(91,991)

(44,953)

(35,722)

(137,827)

Other income (expenses), net

10,269

(5,375)

7,002

(1,851)

(4,787)

Income before income taxes

252,707

204,164

87,858

68,477

226,494

Taxes on income

(35,689)

(27,957)

(12,830)

(10,014)

(22,913)

Income after taxes on income

217,018

176,207

75,028

58,463

203,581

Equity in net earnings of affiliated companies

14,625

9,247

4,284

2,395

12,275

Net income

$        231,643

$        185,454

$          79,312

$          60,858

$        215,856

Less: net income attributable to non-controlling interests

(498)

(331)

(206)

(155)

(725)

Net income attributable to Elbit Systems Ltd.’s shareholders

$        231,145

$        185,123

$          79,106

$          60,703

$        215,131

Earnings per share attributable to Elbit Systems Ltd.’s shareholders:

Basic net earnings per share

$               5.20

$               4.17

$               1.78

$               1.37

$              4.85

Diluted net earnings per share

$               5.18

$               4.15

$               1.77

$               1.36

$             4.82

Weighted average number of shares used in computation of:

Basic earnings per share (in thousands)

44,472

44,351

44,478

44,360

44,375

Diluted earnings per share (in thousands)

44,633

44,579

44,618

44,642

44,592

 

 

ELBIT SYSTEMS LTD.

CONSOLIDATED STATEMENTS OF CASH FLOW

(In thousands of US Dollars)

Nine months
ended
September 30,
2024

Nine months
ended
September 30,
2023

Year ended
December 31,
2023

CASH FLOWS FROM OPERATING ACTIVITIES

Net income

$         231,643

$         185,454

$         215,856

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

117,145

123,477

164,799

Stock-based compensation

10,060

9,732

12,141

Amortization of series B, C and D related issuance costs, net

358

445

579

Deferred income taxes and reserve, net

12,124

4,025

(13,165)

Gain on sale of property, plant and equipment

(419)

(241)

(651)

Loss on sale of investment, remeasurement of investments held under fair value method

6,079

6

4,990

Equity in net (earnings) losses of affiliated companies, net of dividend received (*)

(6,085)

5,060

10,046

Changes in operating assets and liabilities, net of amounts acquired:

Increase in trade and unbilled receivables and prepaid expenses

(466,738)

(65,444)

(96,594)

Increase in inventories, net

(529,345)

(345,201)

(351,594)

Increase (decrease) in trade payables and other payables and accrued expenses

(1,726)

30,999

175,446

Severance, pension and termination indemnities, net

(28,734)

(20,892)

(24,331)

Increase (decrease) in contract liabilities

738,177

(127,451)

16,187

Net cash (used in) provided by operating activities

82,539

(200,031)

113,709

CASH FLOWS FROM INVESTING ACTIVITIES

Purchase of property, plant and equipment and other assets(***)

(167,002)

(157,787)

(187,037)

Acquisition of subsidiaries, net of cash assumed

(10,380)

(10,380)

Investments in affiliated companies and other companies, net

(3,151)

(2,939)

(5,416)

Proceeds from sale of property, plant and equipment

5,013

600

1,466

Proceeds from sale of a subsidiary and an investments

24,776

151

Investment in short-term deposits, net

7,068

(25,576)

(9,467)

Investment in long-term deposits, net

(335)

83

83

Net cash used in investing activities

(133,631)

(195,999)

(210,600)

CASH FLOWS FROM FINANCING ACTIVITIES

Issuance of shares

7

15

30

Issuance of commercial paper

36,380

313,620

313,620

Repayment of long-term loans

(11,262)

(246,173)

(246,231)

Proceeds from long-term bank loans

20,000

20,000

Repayment of Series B, C and D Notes

(61,862)

(62,434)

(62,434)

Dividends paid (**)

(66,717)

(67,033)

(89,248)

Change in short-term bank credit and loans, net

76,316

347,215

147,475

Net cash provided by (used in) financing activities

(27,138)

305,210

83,212

Net decrease in cash and cash equivalents

(78,230)

(90,820)

(13,679)

CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD

$         197,429

$         211,108

$        211,108

CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD

$         119,199

$         120,288

$        197,429

  (*) Dividend received from affiliated companies and partnerships

$             8,540

$           14,307

$          22,321

(**)  Dividends paid during 2023 included approximately $0.5 million dividends paid by a subsidiary to non-controlling interests.

(***) Purchase of property, plant and equipment included investments in new manufacturing facilities of approximately $87 million
for the nine months ended September 30, 2024, approximately $50 million for the nine months ended September 30, 2023, and
approximately $83 million for the year ended December 31, 2023.

 

 

ELBIT SYSTEMS LTD.:

DISTRIBUTION OF REVENUES

(In millions of US Dollars)

Consolidated revenues by geographical regions:

Nine
months
ended
September
30, 2024

%

Nine
months
ended
September
30, 2023

%

Three
months
ended September
30, 2024

%

Three
months
ended September 30,
2023

%

Year
ended
December 31,
2023

%

Israel

$     1,395.1

28.5

$        730.0

16.8

$        499.0

29.1

$        230.2

15.3

$     1,167.2

19.5

North America

1,082.4

22.1

1,049.6

24.1

386.8

22.5

359.7

24.0

1,417.7

23.7

Europe

1,287.2

26.3

1,329.7

30.6

429.9

25.0

496.9

33.1

1,776.4

29.7

Asia-Pacific

858.4

17.5

968.1

22.3

315.6

18.4

314.2

20.9

1,263.8

21.2

Latin America

111.8

2.3

85.1

2.0

37.9

2.2

26.9

1.8

120.7

2.0

Other countries    

162.8

3.3

186.5

4.2

48.3

2.8

73.7

4.9

228.9

3.9

Total revenue

$     4,897.7

100.0

$     4,349.0

100.0

$     1,717.5

100.0

$     1,501.6

100.0

$     5,974.7

100.0

Consolidated revenues by segments:                                

 

Nine months
ended
September 30,
2024

Nine months
ended
September 30,
2023

Three months
ended
September 30,
2024

Three months
ended
September 30,
2023

Year ended
December 31,
2023

Aerospace

External customers

$            1,216.2

$            1,188.1

$               434.0

$               404.1

$            1,613.2

Intersegment revenue

179.1

181.8

58.2

58.0

260.1

Total

1,395.3

1,369.9

492.2

462.1

1,873.3

C4I and Cyber

External customers

558.4

490.7

198.7

171.7

668.4

Intersegment revenue

39.7

41.8

14.7

16.4

52.7

Total

598.1

532.5

213.4

188.1

721.1

ISTAR and EW

External customers

832.8

735.6

271.2

242.9

996.9

Intersegment revenue

156.0

138.9

52.7

44.2

182.5

Total

988.8

874.5

323.9

287.1

1,179.4

Land

External customers

1,144.0

884.7

402.6

330.0

1,241.0

Intersegment revenue

60.6

52.1

19.2

11.3

65.2

Total

1,204.6

936.8

421.8

341.3

1,306.2

ESA

External customers

1,146.3

1,049.9

411.0

352.9

1,455.2

Intersegment revenue

7.3

5.6

5.6

1.9

9.7

Total

1,153.6

1,055.5

416.6

354.8

1,464.9

Revenues

Total revenues (external customers and intersegment) for reportable segments

5,340.4

4,769.2

1,867.9

1,633.4

6,544.9

Less – intersegment revenue

(442.7)

(420.2)

(150.4)

(131.8)

(570.2)

Total revenues

$            4,897.7

$            4,349.0

$            1,717.5

$            1,501.6

$            5,974.7

 

Logo: https://mma.prnewswire.com/media/2017806/Elbit_Systems_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/elbit-systems-reports-third-quarter-2024-results-302309659.html

SOURCE Elbit Systems Ltd.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

Published

on

By

LAV321demonstrated strong results in its third consecutive year of field trials in Europe

REHOVOT, Israel, Nov. 19, 2024 /PRNewswire/ — Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today announced significant progress in the development of its LAV321 bio-fungicide, targeting downy mildew. Over three years of field trials across Europe, evaluating the efficacy of LAV321 in protecting crops from fungal diseases, LAV321 demonstrated an impressive average efficacy rate of 70% against downy mildew in grapes. These results lead to the decision to advance it to the last stage of product development toward commercialization.

 

 

 

Downy mildew is a damaging foliar disease of grapes, leading to yield losses of up to 75% in key growing areas[1]. The global fungicide market, valued at over $24.5 billion in 2024, is projected to grow to $33.27 billion by 2028, with a compound annual growth rate (CAGR) of 7.9%[2]. As public interest in environmentally friendly farming practices rises and concerns about fungal resistance to chemical solutions increase, ag-biologicals like LAV321 are emerging as preferred solutions to address these challenges and promote sustainable agriculture.

In addition to the field trials targeting downy mildew, during 2024 Lavie Bio also conducted trials evaluating LAV321 for the control of late blight in tomato. The trials demonstrated an average efficacy rate exceeding 60%, equivalent to commonly used copper products, which LAV321 is intended to substitute. Late blight is a key disease in management of tomato and potato crops, creating an estimated $6.7 billion in global damages annually[3].

LAV321 was discovered and optimized through Lavie Bio’s Biology Driven Design (BDD) platform, powered by Evogene’s MicroBoost AI tech-engine. It is designed to integrate seamlessly into farmers’ existing Integrated Pest Management (IPM) practices, enhancing productivity and sustainability while helping to prevent the development of resistance to conventional fungicides.

Amit Noam, Lavie Bio’s CEO, expressed his satisfaction with the announced advancement: “We are very pleased with LAV321’s performance over the last three years of our field trials, as well as in numerous trials conducted by several of our multinational partners. Our target of reaching 70% efficacy against downy mildew this year was successfully achieved, providing validation to our effective solution for key fruit and vegetable diseases, while fitting easily into current IPM practices. I am proud to announce that LAV321 has completed its development and is now entering the pre-commercial stage, with regulatory processes set to begin.”

About Lavie Bio Ltd.

Lavie Bio, a subsidiary of Evogene Ltd., aims to improve food quality, sustainability, and agriculture productivity through the introduction of microbiome-based ag-biological products. Lavie Bio utilizes a proprietary computational predictive platform, the BDD platform, powered by Evogene’s proprietary MicroBoost AI tech-engine, harnessing the power of big data, artificial intelligence, and advanced informatics, for the discovery, optimization and development of bio-stimulant and bio-pesticide products.
For more information, please visit www.lavie-bio.com.

About Evogene Ltd.

Evogene (Nasdaq: EVGN, TASE: EVGN) is a computational biology company aiming to revolutionize the development of life-science based products by utilizing cutting edge technologies to increase the probability of success while reducing development time and cost. Evogene established three unique tech-engines – MicroBoost AI, ChemPass AI and GeneRator AI – leveraging Big Data and Artificial Intelligence and incorporating deep multidisciplinary understanding in life sciences. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).

Evogene uses its tech-engines to develop products through subsidiaries and strategic partnerships. Evogene’s subsidiaries currently utilize the tech-engines to develop human microbiome-based therapeutics by Biomica, ag-biologicals by Lavie Bio, ag-chemicals by AgPlenus, medical cannabis products by Canonic and castor varieties, for the biofuel and other industries, by Casterra. 

For more information, please visit: www.evogene.com

Forward Looking Statements

This press release contains “forward-looking statements” relating to future events. These statements may be identified by words such as “may”, “could”, “expects”, “hopes” “intends”, “anticipates”, “plans”, “believes”, “scheduled”, “estimates”, “demonstrates” or words of similar meaning. For example, Evogene and its subsidiaries are using forward-looking statements in this press release when they discuss public interest in environmentally friendly solutions and the adoption of ag-biologicals like LAV321 as preferred solutions, the integration of farmers of LAV321 and successful achievement of regulatory approvals. Such statements are based on current expectations, estimates, projections and assumptions, describe opinions about future events, involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance. Therefore, actual future results, performance or achievements of Evogene and its subsidiaries may differ materially from what is expressed or implied by such forward-looking statements due to a variety of factors, many of which are beyond the control of Evogene and its subsidiaries, including, without limitation, the current war between Israel and Hamas and any worsening of the situation in Israel such as further mobilizations or escalation in the northern border of Israel and those risk factors contained in Evogene’s reports filed with the applicable securities authority. In addition, Evogene and its subsidiaries rely, and expect to continue to rely, on third parties to conduct certain activities, such as their field-trials and pre-clinical studies, and if these third parties do not successfully carry out their contractual duties, comply with regulatory requirements or meet expected deadlines, Evogene and its subsidiaries may experience significant delays in the conduct of their activities. Evogene and its subsidiaries disclaim any obligation or commitment to update these forward-looking statements to reflect future events or developments or changes in expectations, estimates, projections and assumptions.

Contact:
ir@evogene.com
Tel: +972-8-9311901

[1] Plasmopara viticola the Causal Agent of Downy Mildew of Grapevine: From Its Taxonomy to Disease Management, Kseniia Koledenkova et al. Frontiers in Microbiology, May 2022
[2] EINPresswire: Fungicides Market Growth Analysis With Investment Opportunities For 2024-2033
[3] https://www.ars.usda.gov/news-events/news/research-news/2021/wild-potatoes-tapped-for-late-blight-guard-duty/

Logo: https://mma.prnewswire.com/media/945133/lavie_bio.jpg
Logo: https://mma.prnewswire.com/media/1947468/Evogene.jpg

View original content:https://www.prnewswire.com/news-releases/lavie-bio-advances-its-bio-fungicide-lav321-targeting-downy-mildew-to-pre-commercial-stage-following-successful-2024-field-trial-results-302309731.html

SOURCE Lavie Bio

Continue Reading

Technology

CQG to Offer Day-One Connectivity to New MIAX Futures Exchange Matching Engine

Published

on

By

CQG will Support Access to Products Available on the New MIAX Futures Exchange Onyx Trading Platform

DENVER and CHICAGO, Nov. 19, 2024 /PRNewswire/ — CQG, a leading global provider of high-performance technology solutions for market makers, traders, brokers, commercial hedgers and exchanges, today announced that it will offer day-one access to MIAX Futures Exchange (MIAX Futures) – including new Bloomberg equity index futures contracts when listed – in connection with the planned launch of the exchange’s new Onyx matching engine in June 2025. CQG made the announcement during FIA’s Futures & Options Expo, the industry’s most widely attended conference taking place this week in Chicago. The move will ensure that when Onyx goes live on MIAX Futures, CQG clients will be able to access MIAX Futures products on day one through CQG’s front-end offerings and API connections as part of CQG’s network of exchanges.

Last month, Miami International Holdings, Inc. (MIH) announced the renaming of Minneapolis Grain Exchange, LLC (MGEX), a wholly owned subsidiary of MIH, to MIAX Futures Exchange as part of MIH’s strategy to broaden the range of futures and options products listed on the exchange, including agricultural and financial futures. The announcement came the month after MIH announced it had entered into a licensing agreement with Bloomberg Index Services Limited to develop a suite of index futures, options on futures and cash options products based on a portfolio of benchmarks.

CQG CEO Ryan Moroney said: “We’ve been delighted to work closely with MIH on the development of its new trading engine and to be among the first to enable clients to trade on the MIAX Futures Onyx platform. Our clients are already trading the Minneapolis Hard Red Spring Wheat contract on MIAX Futures and are excited to have additional financial futures products to trade in conjunction with other products on our network, utilizing the full range of CQG tools at their fingertips. We look forward to supporting the exchange to ensure that our clients have seamless access to MIAX Futures products as it transitions to the new engine.”

Thomas P. Gallagher, Chairman and CEO of MIH, said: “We are pleased to have CQG providing connectivity to the MIAX Futures Onyx platform as part of its expected launch in Q2 2025. CQG’s sophisticated trading infrastructure will provide its network of professional traders with direct access to our current and planned derivatives products and aligns with our strategy of expanding access to MIAX Futures through industry-leading trading platforms.”

About CQG

CQG provides the industry’s highest performing solutions for traders, brokers, commercial hedgers and exchanges for their market-related activities globally, including trading, market data, advanced technical analysis, risk management, and account administration. The firm partners with the vast majority of futures brokerage and clearing firms and provides Direct Market Access (DMA) to more than 45 exchanges through its global network of co-located Hosted Exchange Gateways. CQG technology serves as the front end for a variety of exchanges and is increasingly employed as the over-the-counter matching engine for important new markets. CQG’s server-side order management tools for spreading, market aggregation, and smart orders are unsurpassed for speed and ease of use. Its market data feed consolidates 85 sources, including exchanges worldwide for futures, options, fixed income, foreign exchange, and equities, as well as data on debt securities, industry reports, and financial indices. One of the longest-serving technology solutions providers in the industry, CQG has won numerous awards for its trading software, technical analysis and multi-asset trading platform. CQG is headquartered in Denver, with sales and support offices and data centers in key markets globally, providing services in more than 60 countries. For more information, visit www.cqg.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cqg-to-offer-day-one-connectivity-to-new-miax-futures-exchange-matching-engine-302309687.html

SOURCE CQG

Continue Reading

Technology

Altair Technology Powers Cleveland Golf’s New HiBore XL Driver

Published

on

By

Altair® HyperWorks® platform empowers Cleveland Golf to break free from traditional design limits

TROY, Mich., Nov. 19, 2024 /CNW/ — Altair (Nasdaq: ALTR), a global leader in computational intelligence, announced its latest collaboration with Cleveland Golf, a leading golf equipment manufacturer, on the design of the new HiBore XL Driver. With Altair’s advanced simulation and design technology, Cleveland Golf is raising the bar for golf equipment and redefining the limits of driver design.

“Altair’s technology and expertise is helping Cleveland Golf shape the future of golf – one swing at a time,” said Sam Mahalingam, chief technology officer, Altair. “Technologies like simulation, artificial intelligence (AI), data analytics, and digital twin are opening a new world of possibilities for sports equipment manufacturers. Altair is excited to see how leading manufacturers like Cleveland Golf can use these tools to transform the way professionals and nonprofessionals alike play their favorite sports.”

Cleveland Golf utilized an array of products within the Altair® HyperWorks® platform to craft the HiBore XL, allowing the team to perform concept evaluation, rapid design exploration, physics-based simulation and optimization, and design for manufacturing. The flexibility of the Altair HyperWorks platform allowed Cleveland Golf to explore a multitude of feasible designs—an exploration that would have been impossible with physical testing alone.

“With the HiBore XL, we sought to equip players with a driver unbound by the traditional limits of shaping, delivering exciting new performance accomplishments. Altair empowered us with the technology to do just that,” said Jacob Lambeth, research engineering supervisor at Cleveland Golf. “We pride ourselves on being at the cutting edge, and today, that means embracing the market’s premier simulation and design software. Collaborating with Altair helps us innovate in brand-new ways and maintain our reputation for pushing the limits of club design.”

With the HiBore XL, Cleveland Golf’s objective was to break free from traditional geometry to achieve new combinations of performance, while still meeting United States Golf Association (USGA) club requirements. Altair HyperWorks provided the team with the advanced design and simulation tools needed to rapidly iterate and unlock new levels of performance. In addition, the two organizations co-created a custom ribbing optimization process that helped Cleveland Golf find rib configurations that increased the HiBore XL’s stiffness while saving weight. The process helped the Cleveland Golf team enhance the club’s sound and improve its center of gravity and moment of inertia (MOI).

The HiBore XL is a testament to the effectiveness of Altair’s best-in-class technology and the strength of the collaboration with the Cleveland Golf engineering team. By combining Cleveland Golf’s vision and know-how with Altair’s technology, expertise, and value-driven approach, the two built more than a driver – they built an innovative approach for success.

To learn more about Cleveland Golf’s new HiBore XL driver, visit clevelandgolf.com. To learn more about the Altair HyperWorks platform, visit https://altair.com/altair-hyperworks.

About Altair

Altair is a global leader in computational intelligence that provides software and cloud solutions in simulation, high-performance computing (HPC), data analytics, and AI. Altair enables organizations across all industries to compete more effectively and drive smarter decisions in an increasingly connected world – all while creating a greener, more sustainable future. To learn more, please visit www.altair.com.

About Dunlop Sports Americas

Based in Huntington Beach, CA and Greenville, SC, Dunlop Sports Americas (DSA) is the North American subsidiary of Sumitomo Rubber Industries, Ltd. We manufacture and sell premium golf and racket sports equipment to players of all skill levels under a portfolio of brands: Dunlop, Srixon, Cleveland Golf, and XXIO. DSA is also a licensed exclusive distributor of ASICS golf footwear. Our unique global sales network and infrastructure in R&D, manufacturing, and material science elevates our brands onto a global stage where we encourage players from around the world to experience our incredible products. For more information, please contact Noelle Zavaleta at noellezavaleta@clevelandgolf.com.

Media contacts

Altair Corporate

Altair Investor Relations

Bridget Hagan

Stephen Palmtag

+1.216.769.2658

+1.669.328.9111

corp-newsroom@altair.com

ir@altair.com

Altair Europe/The Middle East/Africa

Altair Asia-Pacific

Louise Wilce

Man Wang

+44 (0)7392 437 635

86-21-5016635,,825

emea-newsroom@altair.com

apac-newsroom@altair.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/altair-technology-powers-cleveland-golfs-new-hibore-xl-driver-302309472.html

SOURCE Altair

Continue Reading

Trending